Priti Gros1, Aleksandar Videnovic2. 1. Division of Neurology, University of Toronto, Toronto, ON, Canada. 2. Movement Disorders Unit, Division of Sleep Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Abstract
PURPOSE OF REVIEW: Sleep disorders are among the most challenging non-motor features of Parkinson's disease (PD) and significantly affect quality of life. Research in this field has gained recent interest among clinicians and scientists and is rapidly evolving. This review is dedicated to sleep and circadian dysfunction associated with PD. RECENT FINDINGS: Most primary sleep disorders may co-exist with PD; majority of these disorders have unique features when expressed in the PD population. SUMMARY: We discuss the specific considerations related to the common sleep problems in Parkinson's disease including insomnia, rapid eye movement sleep behavior disorder, restless legs syndrome, sleep disordered breathing, excessive daytime sleepiness and circadian rhythm disorders. Within each of these sleep disorders, we present updated definitions, epidemiology, etiology, diagnosis, clinical implications and management. Furthermore, areas of potential interest for further research are outlined.
PURPOSE OF REVIEW: Sleep disorders are among the most challenging non-motor features of Parkinson's disease (PD) and significantly affect quality of life. Research in this field has gained recent interest among clinicians and scientists and is rapidly evolving. This review is dedicated to sleep and circadian dysfunction associated with PD. RECENT FINDINGS: Most primary sleep disorders may co-exist with PD; majority of these disorders have unique features when expressed in the PD population. SUMMARY: We discuss the specific considerations related to the common sleep problems in Parkinson's disease including insomnia, rapid eye movement sleep behavior disorder, restless legs syndrome, sleep disordered breathing, excessive daytime sleepiness and circadian rhythm disorders. Within each of these sleep disorders, we present updated definitions, epidemiology, etiology, diagnosis, clinical implications and management. Furthermore, areas of potential interest for further research are outlined.
Authors: Richard P Allen; Crystal Chen; Diego Garcia-Borreguero; Olli Polo; Sarah DuBrava; Jeffrey Miceli; Lloyd Knapp; John W Winkelman Journal: N Engl J Med Date: 2014-02-13 Impact factor: 91.245
Authors: Stuart J McCarter; Christopher L Boswell; Erik K St Louis; Lucas G Dueffert; Nancy Slocumb; Bradley F Boeve; Michael H Silber; Eric J Olson; Maja Tippmann-Peikert Journal: Sleep Med Date: 2013-01-23 Impact factor: 3.492
Authors: Roselyne M Rijsman; Louise F Schoolderman; Rob S Rundervoort; Maartje Louter Journal: Parkinsonism Relat Disord Date: 2014-01 Impact factor: 4.891
Authors: Nancy A Collop; W McDowell Anderson; Brian Boehlecke; David Claman; Rochelle Goldberg; Daniel J Gottlieb; David Hudgel; Michael Sateia; Richard Schwab Journal: J Clin Sleep Med Date: 2007-12-15 Impact factor: 4.062
Authors: Alex Iranzo; Eduard Tolosa; Ellen Gelpi; José Luis Molinuevo; Francesc Valldeoriola; Mónica Serradell; Raquel Sanchez-Valle; Isabel Vilaseca; Francisco Lomeña; Dolores Vilas; Albert Lladó; Carles Gaig; Joan Santamaria Journal: Lancet Neurol Date: 2013-04-03 Impact factor: 44.182
Authors: Alex Iranzo; Ana Fernández-Arcos; Eduard Tolosa; Mónica Serradell; José Luis Molinuevo; Francesc Valldeoriola; Ellen Gelpi; Isabel Vilaseca; Raquel Sánchez-Valle; Albert Lladó; Carles Gaig; Joan Santamaría Journal: PLoS One Date: 2014-02-26 Impact factor: 3.240
Authors: Michal Rolinski; Konrad Szewczyk-Krolikowski; Paul R Tomlinson; Kannan Nithi; Kevin Talbot; Yoav Ben-Shlomo; Michele Tm Hu Journal: J Neurol Neurosurg Psychiatry Date: 2013-11-01 Impact factor: 10.154
Authors: Mónica M Kurtis; Roberta Balestrino; Carmen Rodriguez-Blazquez; Maria João Forjaz; Pablo Martinez-Martin Journal: Front Neurol Date: 2018-05-29 Impact factor: 4.003
Authors: Jeremy Hunt; Elizabeth J Coulson; Rajendram Rajnarayanan; Henrik Oster; Aleksandar Videnovic; Oliver Rawashdeh Journal: Mol Neurodegener Date: 2022-01-09 Impact factor: 14.195